The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

The prospect of Lundbeck and Otsuka’s Rexulti becoming part of a new treatment for post-traumatic stress disorder (PTSD) ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

Glofitamab is a bispecific CD20-directed CD3 T-cell engager approved under the brand name Columvi ® for the treatment of adults with R/R DLBCL, not otherwise specified or large B-cell lymphoma arising ...

Mushrooms sold across two states have been recalled over fears they could be harboring listeria, a bug that "can cause serious and sometimes fatal infections." ...

Kilwins Quality Confections, LLC. issued a voluntary recall for Mocha Truffles products due to possible undeclared pecans.

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...

Hinge Health's strong partnerships, high client retention, and integration with major health plans drive predictable revenue and market expansion. Learn more on HNGE stock here.

ImmunityBio sees bullish momentum from ASCO data and UK approval for ANKTIVA, despite FDA and cash risks. Check out why IBRX ...

Most investors don’t see the drugmaker’s executive management as credible, following the failure to disclose a patient death, ...

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

More than 57,000 bottles of prescription cholesterol medication Pitavastatin are being recalled due to quality concerns, according to a report from the U.S. Food and Drug Administration. The FDA ...